Home
Karl Henning Kalland's picture

Karl Henning Kalland

Professor
  • E-mailKalland@uib.no
  • Phone+47 55 58 45 06+47 953 30 352
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2023). GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2. Frontiers in Immunology. 15 pages.
  • Show author(s) (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. Cancer Immunology and Immunotherapy.
  • Show author(s) (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. Biomedicines. 14 pages.
  • Show author(s) (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. Frontiers in Pharmacology. 15 pages.
  • Show author(s) (2021). Evaluation of β-catenin inhibition of axitinib and nitazoxanide in human monocyte-derived dendritic cells. Biomedicines. 1-18.
  • Show author(s) (2020). Dual pro- and anti-inflammatory features of monocyte-derived dendritic cells. Frontiers in Immunology. 1-15.
  • Show author(s) (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. Clinical Cancer Research. 334-345.
  • Show author(s) (2018). Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer. Nature Chemical Biology. 94-101.
  • Show author(s) (2018). Screening for viral nucleic acids in vestibular schwannoma. Journal of Neurovirology. 730-737.
  • Show author(s) (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLOS ONE. 1-21.
  • Show author(s) (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. Pharmacology Research & Perspectives. 1-15.
  • Show author(s) (2017). Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts. BMC Cancer. 1-13.
  • Show author(s) (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. OncoTarget. 106989-107001.
  • Show author(s) (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. Scientific Reports. 1-12.
  • Show author(s) (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. British Journal of Cancer. 378-387.
  • Show author(s) (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. PLOS ONE. 1-20.
  • Show author(s) (2016). Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. BMC Cancer. 17 pages.
  • Show author(s) (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer. 15 pages.
  • Show author(s) (2016). Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proceedings of the National Academy of Sciences of the United States of America. 9339-9344.
  • Show author(s) (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. OncoTarget. 9696-9707.
  • Show author(s) (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. OncoTarget. 49289-49298.
  • Show author(s) (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. OncoTarget. 39676-39691.
  • Show author(s) (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. OncoTarget. 1327-1339.
  • Show author(s) (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. OncoTarget. 10634-10645.
  • Show author(s) (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. OncoTarget. 28440-28452.
  • Show author(s) (2014). Switch in FOXA1 status associates with endometrial cancer progression. PLOS ONE.
  • Show author(s) (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. Molecular Cancer Research. 754-764.
  • Show author(s) (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. OncoTarget. 1052-1061.
  • Show author(s) (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. British Journal of Cancer. 78-84.
  • Show author(s) (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. Gynecologic Oncology. 599-606.
  • Show author(s) (2013). p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLOS ONE. 12 pages.
  • Show author(s) (2013). MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. International Journal of Cancer. 544-555.
  • Show author(s) (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. Clinical Cancer Research. 1094-1105.
  • Show author(s) (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLOS ONE. 9 pages.
  • Show author(s) (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clinical Cancer Research. 2331-2341.
  • Show author(s) (2013). Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 7090-7100.
  • Show author(s) (2013). Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model. PLOS ONE. 11 pages.
  • Show author(s) (2013). Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. Cell Proliferation. 554-562.
  • Show author(s) (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. Modern Pathology. 428-434.
  • Show author(s) (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 8699-8704.
  • Show author(s) (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. British Journal of Cancer. 1682-1688.
  • Show author(s) (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. BMC Cancer. 7 pages.
  • Show author(s) (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. British Journal of Cancer. 1997-2004.
  • Show author(s) (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLOS ONE.
  • Show author(s) (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. BMC Cancer. 10 pages.
  • Show author(s) (2011). Transcribed DNA is preferentially located in the perichromatin region of mammalian cell nuclei. Experimental Cell Research. 433-444.
  • Show author(s) (2011). Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. Experimental Cell Research. 234-247.
  • Show author(s) (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. British Journal of Cancer. 921-926.
  • Show author(s) (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. American Journal of Pathology. 861-871.
  • Show author(s) (2011). Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PLOS ONE. 15 pages.
  • Show author(s) (2010). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation. European Journal of Haematology. 239-251.
  • Show author(s) (2010). Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics. 15 pages.
  • Show author(s) (2009). TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. APMIS - Journal of Pathologiy, Microbiology and Immunology. 575-582.
  • Show author(s) (2009). Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators. British Journal of Haematology. 53-68.
  • Show author(s) (2009). Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors; release profile and pharmacological modulaion. European Journal of Haematology. 239-251.
  • Show author(s) (2009). Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia. British Journal of Haematology. 53-68.
  • Show author(s) (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 4834-4839.
  • Show author(s) (2009). Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. PLOS ONE.
  • Show author(s) (2009). Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell-like phenotype. Neuropathology and Applied Neurobiology. 380-393.
  • Show author(s) (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLOS ONE. 14 pages.
  • Show author(s) (2009). Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer.
  • Show author(s) (2009). Cytokines are produced locally by myocytes in rat skeletal muscle during endotoxemia. American Journal of Physiology. Heart and Circulatory Physiology. H735-H744.
  • Show author(s) (2008). WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. Clinical Cancer Research. 1397-1406.
  • Show author(s) (2008). Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia. 287-293.
  • Show author(s) (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. British Journal of Cancer. 1662-1669.
  • Show author(s) (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. PLOS ONE.
  • Show author(s) (2007). Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 332-341.
  • Show author(s) (2007). Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. Clinical Cancer Research. 892-897.
  • Show author(s) (2007). Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. Journal of Neuro-Oncology. 191-202.
  • Show author(s) (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukamia cells indentify patient subgroups that differ susceptibility to histone deactylase inhibitors. International Journal of Oncology. 1529-1538.
  • Show author(s) (2007). ERG upregulation and related ETS transcription factors in prostate cancer. International Journal of Oncology. 19-32.
  • Show author(s) (2007). Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. Analytical Biochemistry. 46-58.
  • Show author(s) (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. International Journal of Oncology. 1065-1080.
  • Show author(s) (2006). Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2 : Bax ratio and low levels of heat shock protein 70 and 90. Leukemia Research. 1531-1540.
  • Show author(s) (2006). Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 16466-16471.
  • Show author(s) (2006). A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clinical Cancer Research. 3985-3992.
  • Show author(s) (2005). Nucleic-acid based diagnostics in clinical microbiology. Tidsskrift for Den norske legeforening. 3110-3114.
  • Show author(s) (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
  • Show author(s) (2005). CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry. 18-27.
  • Show author(s) (2003). Cellular localisation and nuclear export of the human bZIP transcription factor TCF11. Biochimica et Biophysica Acta. 143-151.
  • Show author(s) (2002). Rev inhibition strongly affects intracellular distribution of HIV-1 RNAs. Journal of Virology. 10473-10484.
  • Show author(s) (2002). Nuclear import of factors involved in signaling is inhibited in C3H/10T1/2 cells treated with tetradecylthioacetic acid. Journal of Lipid Research. 1630-1640.
  • Show author(s) (2002). Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses. Journal of Hematotherapy & Stem Cell Research. 469-481.
  • Show author(s) (2001). Mitochondrial protein p32 can accumulate in the nucleus. Biochemical and Biophysical Research Communications - BBRC. 1161-1169.
  • Show author(s) (2000). Identification of a nuclear ribonucleoprotein particle which contains incompletely spliced HIV-1 RNAs. Biochemical and Biophysical Research Communications - BBRC. 509-513.
  • Show author(s) (1999). Nukleinsyrebasert mikrobiolgoisk diagnostikk. Tidsskrift for Den norske legeforening. 802-809.
  • Show author(s) (1999). Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs. Journal of General Virology. 1965-1974.
  • Show author(s) (1999). A trans-dominant negative mutant of the HIV-1 Rev protein affects the Rev-dependent splicing pattern and expression of HIV RNA. Journal of General Virology. 1965-1974.
  • Show author(s) (1998). Visualisation of ribosomal RNA (rRNA) synthesis in eukaryotic cells in culture. Methods in Cell Science. 295-302.
  • Show author(s) (1998). Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. Virology. 473-482.
  • Show author(s) (1998). Labelling of eukaryotic RNA transcripts with BrUTP using liposomal (DOTAP) and non-liposomal (FuGENE 6) transfection reagents: new application for transfection reagents. Biochemica. 45-46.
  • Show author(s) (1998). Histographic recording of human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev and nuclear factors. APMIS - Journal of Pathologiy, Microbiology and Immunology. 623-635.
  • Show author(s) (1997). Oligomerization of HIV-1 Rev mutants in the cytoplasm and during nuclear import. Virology. 73-81.
  • Show author(s) (1997). Labelling of RNA transcripts of eukaryotic cells in culture with Br UTP using a liposome transfection reagent (DOTAP). BioTechniques. 308-312.
  • Show author(s) (1996). Immunoglobin G sublass antibodies to rubella viruses in chronic liver disease, acute rubella and healthy controls. FEMS Immunology and Medical Microbiology. 43-50.
  • Show author(s) (1996). HIV-1 proviral DNA sequences of env PCR amplificates from Tanzania. APMIS - Journal of Pathologiy, Microbiology and Immunology. 459-464.
  • Show author(s) (1995). Raised levels of antibodies to human viruses at the clinical onset of autoimmune chronic active hepatitis. Journal of Viral Hepatitis. 159-164.
  • Show author(s) (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutants. Journal of Virology. 3315-3323.
  • Show author(s) (1994). Viral antibodies in infectious mononucleosis. FEMS Immunology and Medical Microbiology. 219-224.
  • Show author(s) (1994). Radioimmunoprecipitation and immunoblot studies of antibodies to rubella virus in patients with chronic liver disease. Archives of Virology. 73-85.
  • Show author(s) (1994). Elevated rubella antibodies in patients with chronic liver diseases. Journal of Medical Virology. 30-36.
  • Show author(s) (1993). Diagnosis of infection with human T-cell lymphotropic virus type 2 (HTL V-2) in Norwegian HIV infected individuals. Clinical and Diagnostic Virology. 143-152.
  • Show author(s) (1991). Viral RNA species in cell lines persistently and lytically infected with measles virus. APMIS - Journal of Pathologiy, Microbiology and Immunology. 42-48.
  • Show author(s) (1991). Study of transcription in measles virus infected Vero cells using cDNA probes prepared from poly(A)RNA from uninfected and infected cells. APMIS - Journal of Pathologiy, Microbiology and Immunology. 33-41.
  • Show author(s) (1991). Rex-dependent nucleolar accumulation of HTLV-1 mRNA. The New Biologist. 389-397.
  • Show author(s) (1991). Replication of HIV-1 in primary dendritic cell cultures. Proceedings of the National Academy of Sciences of the United States of America. 7998-8002.
  • Show author(s) (1991). Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures. Microbial Pathogenesis. 297-304.
  • Show author(s) (1990). Applications of Magnetic Beads With Covalently Attached Oligonucleotides in Hybridization: Isolation and Detection of Specific Measles Virus mRNA from Crude Cell Lysate. Analytical Biochemistry. 40-50.
  • Show author(s) (1989). Mechanism of spontaneous loss of heat-stable toxin (STa) Production in enterotoxigenic Escherichia coli. APMIS - Journal of Pathologiy, Microbiology and Immunology. 436-440.
  • Show author(s) (1988). Comparative Study of Colony Hybridization With Synthetic Oligonucleotide Probes and Enzyme-Linked Immunosorbent Assay for Identification of Enterotoxigenic Escherichia Coli. Journal of Clinical Microbiology. 530-534.
Lecture
  • Show author(s) (2023). Drug Discovery and Development - CryoIT clinical trial updates.
  • Show author(s) (2022). SARS-Cov-2 - virusevolusjon og immunrespons.
  • Show author(s) (2022). Enhanced cryoimmunotherapy of urogenital cancers.
  • Show author(s) (2021). Virologisk evolusjon og immunrespons.
  • Show author(s) (2021). SARS-Cov-2 - virusevolusjon og immunrespons.
Popular scientific lecture
  • Show author(s) (2022). Ny kreftbehandling i Bergen.
  • Show author(s) (2022). Enhanced cryoimmunotherapy against urogenital cancers.
  • Show author(s) (2022). Cryoimmunterapi som ny kreftbehandling.
  • Show author(s) (2022). Cryoimmunterapi som ny kreftbehandling.
  • Show author(s) (2022). Cryoimmunterapi som ny kreftbehandling.
  • Show author(s) (2020). Utvikling og fremskritt i kreftforskning og kreftbehandling .
  • Show author(s) (2007). Virus og kreft.
  • Show author(s) (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer.
Academic lecture
  • Show author(s) (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC) .
  • Show author(s) (2023). Circulating tumor cell enumeration and ultradeep T-cell receptor-sequencing in a Phase I clinical trial of metastatic prostate cancer.
  • Show author(s) (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function.
  • Show author(s) (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
  • Show author(s) (2009). EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture.
  • Show author(s) (2009). A novel cell culture model of prostate carcinogenesis and its utility in phenotypic screening of small molecular compounds.
  • Show author(s) (2008). Targeting master regulatory mechanisms in cancer therapy using novel small molecular compounds – basic mechanisms, in vitro and in vivo screening and development towards the clinic.
  • Show author(s) (2008). Regulatory patterns of prostate carcinogenesis and development of a cell culture experimental system.
  • Show author(s) (2008). Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer.
  • Show author(s) (2008). Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules.
  • Show author(s) (2007). Functional oncogenomics and epigenomics analysis of prostate cancer.
  • Show author(s) (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes.
  • Show author(s) (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
  • Show author(s) (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy.
  • Show author(s) (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines.
  • Show author(s) (2006). ERG upregulation in relation to other transcription factors in prostate cancer.
  • Show author(s) (2006). ERG upregulation and related transcription factors in prostate cancer.
  • Show author(s) (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer.
  • Show author(s) (2005). Onkogene, hepatotrope virus – molekylære mekanismer ved utvikling av hepatocellulært carcinom (HCC).
  • Show author(s) (2005). Nuclear localization of active genes and their transcripts.
  • Show author(s) (2005). Discovering candidate genes that distinguish between CML and AML using microarrays.
  • Show author(s) (2004). Virus and cancer models.
  • Show author(s) (2004). Real time quantitative PCR and hepatitis C monitoring.
  • Show author(s) (2004). Global analysis of gene expression and regulatory modules in cancer tissue.
  • Show author(s) (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
  • Show author(s) (2004). Gene expression profiles in prostate cancer: identification of upregulated SIM2 gene validated in archival tissue, relation to histological grading and prognosis.
  • Show author(s) (2003). Virus og Cancer.
  • Show author(s) (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
  • Show author(s) (2003). Global analysis of gene expression and regulatory patterns in cancer.
  • Show author(s) (2003). Global analysis of gene expression and regulatory patterns in acute myeloid leukemia.
  • Show author(s) (2003). Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation.
  • Show author(s) (2003). Gene expression profiling in prostate cancer.
  • Show author(s) (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
  • Show author(s) (2001). Global gene expression profiling using DNA microarrays - pitfalls and outlook.
  • Show author(s) (2001). Global analysis of gene expression in human cancer.
  • Show author(s) (2001). Angiostatin release from alginate encapsulated 293-cells.
Book review
  • Show author(s) (2007). Immunologiske refleksjonar - "Defending Life" av Elling Ulvestad, London - Springer forlag ISBN 978-1-4020-5675-8. Tidsskrift for Den norske legeforening. 3298-3299.
Popular scientific article
  • Show author(s) (1998). HIV som modellsystem til forståing av genekspresjon. Naturen. 67-77.
Feature article
  • Show author(s) (1993). HTLV-I-infeksjon i Norge. Natl Inst Publ Health Rep (MSIS).
Doctoral dissertation
  • Show author(s) (2018). Regulatory patterns in prostate cell differentiation – investigation of transcription factors AR, GATA2 and NKX3-1.
  • Show author(s) (2017). Context dependent transcription factor regulation in normal and malignant cell differentiation.
  • Show author(s) (1989). Studies on measles virus in lytic and persistent infections ; Construction and use of measles virus specific nucleic acid probes.
Interview
  • Show author(s) (2007). Livmorhalskreft.
  • Show author(s) (2005). Legionella og andre bakterier.
  • Show author(s) (2005). Gades Institutt - presentasjon.
  • Show author(s) (2005). Gades Institutt - presentasjon.
  • Show author(s) (2003). Bakterier og virus - slik beskytter du deg.
  • Show author(s) (2001). Bakterier og virus.
Academic chapter/article/Conference paper
  • Show author(s) (2017). Models of Tumor Progression in Prostate Cancer. 16 pages.
  • Show author(s) (2009). Molecular Microbiological Diagnostics.
  • Show author(s) (1998). Mikrobiologisk diagnostikk. Kapittel om Nukleinsyrebasert diagnostikk.
  • Show author(s) (1991). Retroviral regulatory proteins and the nucleolus. 14 pages.
  • Show author(s) (1991). HIV-1 infection of human dendritic cells. 15 pages.
Abstract
  • Show author(s) (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. International Journal of Gynecological Cancer. 1 pages.
  • Show author(s) (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. Virchows Archiv. S18-S18.
  • Show author(s) (2011). TUMOR-ASSOCIATED GLIAL CELLS PROMOTE GROWTH OF GBM XENOGRAFTS IN EGFP NOD/SCID MICE. Neuro-Oncology. 55-55.
  • Show author(s) (2009). PRIMARY HUMAN ACUTE MYELOGENOUS LEUKEMIA CELLS SHOW CONSTITUTIVE RELEASE OF SEVERAL MATRIX METALLOPROTEASES AND THEIR INHIBITORS. Haematologica. 545-545.
  • Show author(s) (2007). Release of angiopoietin-1 by acute myelogenous leukemia (AML) cells is increased by stromal cells and associated with mutations in the nucleophosmin (NPM) gene. Experimental Hematology. 72-72.
  • Show author(s) (2007). Linking susceptibility to histone deactylase inhibitors and basal gene expression profiles in acute myeloid leukaemia. Experimental Hematology. 77-77.
  • Show author(s) (2007). Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in the susceptibility to histone deacetylase inhibitors. Haematologica. 112-112.
  • Show author(s) (2006). cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation. NBS-nytt. 106.
  • Show author(s) (2006). The early gene expression signature of acute myeloid leukemia (AML) blasts during in vivo chemotherapy. International Journal of Molecular Medicine. S65.
  • Show author(s) (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. International Journal of Molecular Medicine. S27.
  • Show author(s) (2006). ERG upregulation in relation to other transcription factors in prostate cancer. NBS-nytt. 72.
  • Show author(s) (2005). Single-minded 2 homolog gene is overexpressed in prostate cancer. Virchows Archiv. 432-432.
  • Show author(s) (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. International Journal of Molecular Medicine. S76-S76.
Academic literature review
  • Show author(s) (2021). Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System . Cancers. 17 pages.
  • Show author(s) (2018). Targeting Wnt/β-catenin signaling for cancer immunotherapy. TIPS - Trends in Pharmacological Sciences. 648-658.
  • Show author(s) (2009). Tumor virology - history, status and future challenges. APMIS - Journal of Pathologiy, Microbiology and Immunology. 382-399.
  • Show author(s) (2007). Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in Acute Myeloid Leukemia. Current Pharmaceutical Biotechnology. 344-354.
  • Show author(s) (2007). Early gene expression of acute myeloid leukemia in response to chemotherapy. Expert Review of Anticancer Therapy. 741-751.
Brochure
  • Show author(s) (2021). CCBIO Annual Report 2020 - Prostate Cancer Therapy Research Group p. 36.
  • Show author(s) (2021). CCBIO Annual Report 2020 - CryoIT pp. 22-23.
  • Show author(s) (2020). Newsletter CryoIT Desember 2020.
Chapter
  • Show author(s) (2022). Models of Tumor Progression in Prostate Cancer. 453-466. In:
    • Show author(s) (2022). Biomarkers of the Tumor Microenvironment. Springer.
  • Show author(s) (2019). Hepatittvirus. 340-344. In:
    • Show author(s) (2019). Medisinsk mikrobiologi. Gyldendal Akademisk.
  • Show author(s) (2009). Molecular microbial diagnostics. 336-364. In:
    • Show author(s) (2009). Molecular Biology and Biotechnology 5th Ed. Springer.

More information in national current research information system (CRIStin)